Peroxisome Proliferator-Activated Receptor (PPAR)γ can inhibit chronic renal allograft damage

Chronic inflammation and fibrosis are the leading causes of chronic allograft failure. The nuclear receptor peroxisome proliferator-activated receptor (PPAR)γ is a transcription factor known to have antidiabetogenic and immune effects, and PPARγ forms obligate heterodimers with the retinoid X recept...

Full description

Bibliographic Details

Main Authors:	Kiss, Eva (Author) , Popovic, Zoran V. (Author) , Bedke, Jens (Author) , Adams, Judith (Author) , Bonrouhi, Mahnaz (Author) , Babelova, Andrea (Author) , Schmidt, Claudia (Author) , Edenhofer, Frank (Author) , Zschiedrich, Inka C. (Author) , Domhan, Sophie (Author) , Abdollahi, Amir (Author) , Schäfer, Liliana (Author) , Gretz, Norbert (Author) , Porubský, Štefan (Author) , Gröne, Hermann-Josef (Author)
Format:	Article (Journal)
Language:	English
Published:	16 December 2010
In:	The American journal of pathology Year: 2010, Volume: 176, Issue: 5, Pages: 2150-2162
ISSN:	1525-2191
DOI:	10.2353/ajpath.2010.090370
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2353/ajpath.2010.090370 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0002944010600120
Author Notes:	Eva Kiss, Zoran V. Popovic, Jens Bedke, Judith Adams, Mahnaz Bonrouhi, Andrea Babelova, Claudia Schmidt, Frank Edenhofer, Inka Zschiedrich, Sophie Domhan, Amir Abdollahi, Liliana Schäfer, Norbert Gretz, Stefan Porubsky, and Hermann-Josef Gröne